April 17, 2018 / 10:53 AM / 7 days ago

BRIEF-Genmab: Q1 Net Sales Of Darzalex At $432 Mln

April 17 (Reuters) - Genmab A/S:

* REG-GENMAB ANNOUNCES NET SALES OF DARZALEX® (DARATUMUMAB) FOR FIRST QUARTER OF 2018

* REG-GENMAB ANNOUNCES NET SALES OF DARZALEX® (DARATUMUMAB) FOR FIRST QUARTER OF 2018

* NET SALES OF DARZALEX IN Q1 OF 2018 TOTALED USD 432 MILLION

* WILL RECEIVE ROYALTIES ON WORLDWIDE SALES FROM JANSSEN BIOTECH, INC Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below